John Trizzino Insider Trading $NVAX NOVAVAX INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Trizzino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Trizzino. John Trizzino is EVP, CBO and CFO in NOVAVAX INC ($NVAX) and EVP, CCO, CBO & Interim CFO in NOVAVAX INC ($NVAX) and EVP, Chief Commercial Officer in NOVAVAX INC ($NVAX) and EVP, CMO and CBO in NOVAVAX INC ($NVAX) and Snr. VP, Int & Govt Alliances in NOVAVAX INC ($NVAX) and SVP, CBO and CFO in NOVAVAX INC ($NVAX) and SVP, Commercial Operations in NOVAVAX INC ($NVAX).
John Trizzino in NOVAVAX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John Trizzino: EVP, CCO, CBO & Interim CFO, EVP, Chief Commercial Officer, EVP, CMO and CBO, EVP, CBO and CFO, SVP, CBO and CFO, SVP, Commercial Operations, Snr. VP, Int & Govt Alliances
Holdings: 704 shares
Current Value: $922
Latest Transaction: May 07 2021
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Trizzino in NOVAVAX INC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 0.00 | 31,900 | 0 | 0 | |
| Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Payment of Exercise | F | 113.56 | 1,709 | 194,074 | 23,408 | 25.1 K to 23.4 K (-6.80 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 0.00 | 3,538 | 0 | 25,117 | 21.6 K to 25.1 K (+16.40 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Payment of Exercise | F | 113.56 | 15,408 | 1,749,732 | 21,579 | 37 K to 21.6 K (-41.66 %) |
| Sep 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 0.00 | 31,900 | 0 | 36,987 | 5.1 K to 37 K (+627.09 %) |
| Aug 26 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 19.08 | 140,000 | 2,671,200 | 140,000 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 46.00 | 10,410 | 478,860 | 14,589 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.60 | 13,322 | 367,687 | 6,677 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.00 | 1,952 | 52,704 | 4,298 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 27.00 | 5,855 | 158,085 | 394 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | M | 99.80 | 11,249 | 1,122,650 | 0 | |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 153.95 | 1,300 | 200,135 | 5,087 | 6.4 K to 5.1 K (-20.35 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 153.16 | 1,708 | 261,597 | 6,387 | 8.1 K to 6.4 K (-21.10 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 152.22 | 4,199 | 639,172 | 8,095 | 12.3 K to 8.1 K (-34.15 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 150.85 | 4,010 | 604,909 | 12,294 | 16.3 K to 12.3 K (-24.60 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 149.83 | 1,800 | 269,694 | 16,304 | 18.1 K to 16.3 K (-9.94 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 149.08 | 6,600 | 983,928 | 18,104 | 24.7 K to 18.1 K (-26.72 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 147.99 | 9,101 | 1,346,857 | 24,704 | 33.8 K to 24.7 K (-26.92 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 146.95 | 8,094 | 1,189,413 | 33,805 | 41.9 K to 33.8 K (-19.32 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 146.21 | 4,900 | 716,429 | 41,899 | 46.8 K to 41.9 K (-10.47 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 143.99 | 300 | 43,197 | 46,799 | 47.1 K to 46.8 K (-0.64 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Sell | S | 142.85 | 776 | 110,852 | 47,099 | 47.9 K to 47.1 K (-1.62 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 46.00 | 10,410 | 478,860 | 47,875 | 37.5 K to 47.9 K (+27.79 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.60 | 13,322 | 367,687 | 37,465 | 24.1 K to 37.5 K (+55.18 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.00 | 1,952 | 52,704 | 24,143 | 22.2 K to 24.1 K (+8.80 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 27.00 | 5,855 | 158,085 | 22,191 | 16.3 K to 22.2 K (+35.84 %) |
| Aug 20 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Buy | M | 99.80 | 11,249 | 1,122,650 | 16,336 | 5.1 K to 16.3 K (+221.13 %) |
| Jun 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 5.95 | 18,400 | 109,480 | 18,400 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 5.95 | 18,400 | 109,480 | 18,400 | |
| Jun 29 2020 | NVAX | NOVAVAX INC | Trizzino John | EVP, CBO and CFO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 5.95 | 100,000 | 595,000 | 100,000 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 5.95 | 18,400 | 109,480 | 18,400 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 0.00 | 10,613 | 0 | 10,613 | |
| Sep 30 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 0.00 | 31,900 | 0 | 31,900 | |
| Sep 12 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Sell | S | 5.72 | 5,578 | 31,911 | 4,800 | 10.4 K to 4.8 K (-53.75 %) |
| Sep 10 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | M | 0.00 | 5,143 | 0 | 0 | |
| Sep 10 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Payment of Exercise | F | 5.50 | 1,713 | 9,422 | 10,378 | 12.1 K to 10.4 K (-14.17 %) |
| Sep 10 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Buy | M | 0.00 | 5,143 | 0 | 12,091 | 6.9 K to 12.1 K (+74.02 %) |
| Mar 12 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 0.00 | 46,887 | 0 | 46,887 | |
| Mar 12 2019 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 0.00 | 102,861 | 0 | 102,861 | |
| Dec 14 2018 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Option Exercise | A | 2.30 | 500,000 | 1,150,000 | 500,000 | |
| May 15 2018 | NVAX | NOVAVAX INC | Trizzino John | SVP, CBO and CFO | Buy | P | 1.64 | 50,000 | 81,995 | 138,965 | 89 K to 139 K (+56.20 %) |
| Dec 19 2017 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 1.38 | 400,000 | 552,000 | 400,000 | |
| Feb 02 2017 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Buy | P | 1.12 | 3,401 | 3,809 | 88,965 | 85.6 K to 89 K (+3.97 %) |
| Nov 16 2016 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 1.35 | 125,000 | 168,750 | 125,000 | |
| Nov 16 2016 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 1.35 | 125,000 | 168,750 | 125,000 | |
| Sep 23 2016 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Buy | P | 2.17 | 46,000 | 99,820 | 85,564 | 39.6 K to 85.6 K (+116.27 %) |
| Mar 17 2016 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 4.99 | 225,000 | 1,122,750 | 225,000 | |
| Feb 01 2016 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Buy | P | 3.63 | 5,855 | 21,254 | 39,564 | 33.7 K to 39.6 K (+17.37 %) |
| Aug 04 2015 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Buy | P | 3.63 | 5,098 | 18,506 | 33,709 | 28.6 K to 33.7 K (+17.82 %) |
| Mar 09 2015 | NVAX | NOVAVAX INC | Trizzino John | SVP, Commercial Ope ... | Option Exercise | A | 8.94 | 200,000 | 1,788,000 | 200,000 | |
| Aug 11 2011 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Buy | P | 1.20 | 10,000 | 12,000 | 10,000 | 0 to 10 K |
| Aug 11 2011 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Buy | P | 1.18 | 10,000 | 11,800 | 10,000 | 0 to 10 K |
| Mar 14 2011 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Option Exercise | A | 2.50 | 100,000 | 250,000 | 420,000 | |
| Mar 17 2010 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
| Jul 21 2009 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Option Exercise | A | 3.02 | 220,000 | 664,400 | 220,000 |